↓ Skip to main content

The Spike Proteins of SARS-CoV-2 B.1.617 and B.1.618 Variants Identified in India Provide Partial Resistance to Vaccine-elicited and Therapeutic Monoclonal Antibodies

Overview of attention for article published in bioRxiv, May 2021
Altmetric Badge

Mentioned by

news
23 news outlets
blogs
1 blog
policy
2 policy sources
twitter
3138 X users
facebook
1 Facebook page
video
1 YouTube creator